Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Baqsimi Generic Name & Formulations
Legal Class
Rx
General Description
Glucagon 3mg; per device; nasal pwd for intranasal use; preservative-free.
Pharmacological Class
Antihypoglycemic.
How Supplied
Pack—1, 2
Manufacturer
Generic Availability
NO
Baqsimi Indications
Indications
Severe hypoglycemia.
Baqsimi Dosage and Administration
Adults and Children
<4yrs: not established. ≥4yrs: 3mg as single spray intranasally into one nostril. May repeat with new device after 15mins if no response. The dose does not require inhalation.
Baqsimi Contraindications
Contraindications
Pheochromocytoma. Insulinoma.
Baqsimi Boxed Warnings
Not Applicable
Baqsimi Warnings/Precautions
Warnings/Precautions
Increased blood pressure. Previously undiagnosed pheochromocytoma. Lack of efficacy in insulinoma; may cause hypoglycemia. Insufficient hepatic glycogen stores (eg, starvation, adrenal insufficiency, chronic hypoglycemia); treat with glucose. Pregnancy. Nursing mothers.
Baqsimi Pharmacokinetics
See Literature
Baqsimi Interactions
Interactions
Transient increase in pulse and blood pressure may occur with beta-blockers. Loss of efficacy or may produce hypoglycemia with indomethacin. May potentiate the anticoagulant effect of warfarin.
Baqsimi Adverse Reactions
Adverse Reactions
Nausea, headache, vomiting, upper respiratory tract irritation (eg, rhinorrhea, nasal discomfort/congestion, cough, epistaxis), watery eyes, redness of eyes, itchy nose/throat/eyes; allergic reactions.
Baqsimi Clinical Trials
See Literature
Baqsimi Note
Not Applicable
Baqsimi Patient Counseling
See Literature
